Boston Scientific Corporation

BSX Healthcare Medical Devices

Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

44.39 0.25 +0.57%
Market cap
$64.0B
P/E
17.9×
Fwd P/E
17.8×
Dividend yield
—
F-score
7/9
Altman Z
5.41
Beneish M
−2.49
Dividend safety
n/a

Boston Scientific Corporation (BSX) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Boston Scientific Corporation (BSX) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 2.4× (October 2026) to 7.1× (February 2025); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.3× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 5.8× (3.44%)
FY2024 6.0× 38.81%
FY2023 4.3× 14.90%
FY2022 3.7× 3.04%
FY2021 3.6× 9.38%
FY2020 3.3× (26.72%)
FY2019 4.5× (18.94%)
FY2018 5.6× 13.22%
FY2017 4.9× 11.98%
FY2016 4.4× 12.74%

Quarterly newest first

Period P/B ratio Change
Jun 2026 2.5× (30.16%)
Mar 2026 3.6× (38.12%)
Dec 2025 5.8× (5.77%)
Sep 2025 6.1× (12.76%)
42 more quarters

Against its own ten years

Low 2.4× High 7.1×
Ten-year median 4.3×
Current reading's percentile 2

P/B ratio against peers

Company P/B ratio
PHG Koninklijke Philips N.V. compare 1.8×
MDT Medtronic PLC compare 2.4×
BSX Boston Scientific Corporation 2.6×
GEHC GE HealthCare Technologies Inc. compare 2.9×
STE STERIS plc compare 3.0×
ABT Abbott Laboratories compare 3.5×
EW Edwards Lifesciences Corporation compare 4.7×
SYK Stryker Corporation compare 4.7×
DXCM DexCom, Inc. compare 12.5×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on BSX